IMFINZI (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the IMFINZI drug offered from AstraZeneca Pharmaceuticals LP. This Programmed Death Ligand-1 Blocker [EPC],Programmed Death Ligand-1 Antagonists [MoA],Programmed Death Ligand-1-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
NON-PROPRIETARY NAME: | Durvalumab |
SUBSTANCE NAME: | DURVALUMAB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Programmed Death Ligand-1 Blocker [EPC],Programmed Death Ligand-1 Antagonists [MoA],Programmed Death Ligand-1-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2017-05-01 |
END MARKETING DATE: | 0000-00-00 |
IMFINZI HUMAN PRESCRIPTION DRUG Details:
Item Description | IMFINZI from AstraZeneca Pharmaceuticals LP |
LABELER NAME: | AstraZeneca Pharmaceuticals LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 120(mg/2.4mL) |
START MARKETING DATE: | 2017-05-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0310-4500_8baba4ea-2855-42fa-9bd9-5a7548d4cec3 |
PRODUCT NDC: | 0310-4500 |
APPLICATION NUMBER: | BLA761069 |
Other DURVALUMAB Pharmaceutical Manufacturers / Labelers: